Similarly, cytokine fusion compounds which deliver for instance TNFα or IFNγ to tumor vessels in PNET induce vessel normalization and/or vessel wall inflammation without TLS formation demonstrating the unique opportunities of targeting LIGHT into the tumor microenvironment (97, 109). This evidence concerns the gene TNFSF14 and neoplasm.